Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Prostatic Neoplasms  [Clear All Filters]
2006
Tande AJ, Platz EA, Folsom AR. "The metabolic syndrome is associated with reduced risk of prostate cancer." Am J Epidemiol. 2006;164(11):1094-102.
2010
Meyer TE, Boerwinkle E, Morrison AC, et al. "Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study." Cancer Epidemiol Biomarkers Prev. 2010;19(2):558-65.
2014
Petrick JL, Reeve BB, Kucharska-Newton AMaria, et al. "Functional status declines among cancer survivors: trajectory and contributing factors." J Geriatr Oncol. 2014;5(4):359-67.
2018
Mondul AM, Joshu CE, Barber JR, et al. "Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study." Cancer Prev Res (Phila). 2018;11(12):779-788.
2019
Hurwitz LM, Joshu CE, Barber JR, et al. "Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case Fatality in the Atherosclerosis Risk in Communities Study." Cancer Epidemiol Biomarkers Prev. 2019;28(3):563-569.
Travis RC, Perez-Cornago A, Appleby PN, et al. "A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk." Cancer Res. 2019;79(1):274-285.
Han P, Bidulescu A, Barber JR, et al. "Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the Atherosclerosis Risk in Communities (ARIC) Study." Cancer Causes Control. 2019;30(4):343-354.
Marrone MT, Selvin E, Barber JR, Platz EA. "Hyperglycemia, Classified with Multiple Biomarkers Simultaneously in Men without Diabetes, and Risk of Fatal Prostate Cancer." Cancer Prev Res (Phila). 2019;12(2):103-112.
Wang A, Barber JR, Tin A, De Marzo AM, Köttgen A, Joshu CE. "Serum Urate, Genetic Variation, and Prostate Cancer Risk: Atherosclerosis Risk in Communities (ARIC) Study." Cancer Epidemiol Biomarkers Prev. 2019;28(7):1259-1261.